Cervical cancer screening rates decline among US women
Analysis based on 10 articles · First reported Aug 27, 2026 · Last updated Sep 02, 2026
The findings may increase demand for cervical cancer screening and HPV vaccination, potentially benefiting companies in diagnostics and vaccines. However, the study itself is unlikely to cause significant market movements, as it is a public health research publication.
A study by researchers at the Medical University of South Carolina's Hollings Cancer Center, published in JAMA Network Open, found that the proportion of US women aged 21-29 who have never been screened for cervical cancer rose from 12.5% in 2005 to 31.9% in 2023, an average annual increase of 5.2%. Among women aged 30-65, the never-screened rate rose from 5.3% to 14.8%. The study, based on National Health Interview Survey data, also noted that regional- and distant-stage cervical cancer incidence increased by over 2% per year since 2017 among women aged 30-64. The authors highlighted disparities, with higher never-screening rates among Asian, Hispanic, and Black women, uninsured women, and those in the South. They also noted that nearly 8 million women aged 21-29 remain unvaccinated against HPV, and almost a third of those have never been screened. The study does not prove causation but underscores missed prevention opportunities.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard